Patents Assigned to R&D-Biopharmaceuticals GmbH
  • Tubulin inhibitors
    Patent number: 9163060
    Abstract: The present invention relates to novel tubulin binding molecules of formula (I) and their use for the treatment of cancer and other diseases.
    Type: Grant
    Filed: November 12, 2010
    Date of Patent: October 20, 2015
    Assignee: R&D BIOPHARMACEUTICALS GMBH
    Inventor: Wolfgang Richter
  • Tubulysine derivatives
    Patent number: 8980833
    Abstract: The present invention relates to novel cytotoxic molecules and their use for the treatment of cancer and other diseases.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: March 17, 2015
    Assignee: R&D-Biopharmaceuticals GmbH
    Inventor: Wolfgang Richter
  • Tubulin inhibitors
    Patent number: 8772244
    Abstract: The present invention relates to novel tubulin binding molecules of formula (I) and their use for the treatment of cancer and other diseases.
    Type: Grant
    Filed: November 12, 2010
    Date of Patent: July 8, 2014
    Assignee: R&D Biopharmaceuticals GmbH
    Inventor: Wolfgang Richter
  • Tubulin Inhibitors
    Publication number: 20120252739
    Abstract: The present invention relates to novel tubulin binding molecules of formula (I) and their use for the treatment of cancer and other diseases.
    Type: Application
    Filed: November 12, 2010
    Publication date: October 4, 2012
    Applicant: R&D Biopharmaceuticals GmbH
    Inventor: Wolfgang Richter
  • Tubulin Inhibitors
    Publication number: 20120252738
    Abstract: The present invention relates to novel tubulin binding molecules of formula (I) and their use for the treatment of cancer and other diseases.
    Type: Application
    Filed: November 12, 2010
    Publication date: October 4, 2012
    Applicant: R & D Biopharmaceuticals GmbH
    Inventor: Wolfgang Richter
  • TUBULYSINE DERIVATIVES
    Publication number: 20120129779
    Abstract: The present invention relates to novel cytotoxic molecules and their use for the treatment of cancer and other diseases.
    Type: Application
    Filed: May 9, 2008
    Publication date: May 24, 2012
    Applicant: R&D-BIOPHARMACEUTICALS GMBH
    Inventor: Wolfgang Richter
  • Tubulysin analogues
    Patent number: 7816377
    Abstract: The invention relates to tubulysin derivatives of general formula (II), said derivatives having a cytostatic effect.
    Type: Grant
    Filed: July 9, 2003
    Date of Patent: October 19, 2010
    Assignee: R&D-Biopharmaceuticals GmbH
    Inventors: Alexander Dömling, Bernd Henkel, Barbara Beck, Katrin Illgen, Sukumar Sakamuri, Sanjay Menon
  • Macrocycles for the treatment of cancer
    Patent number: 7807710
    Abstract: The invention relates to the novel macrocycles of general formula (I) and to their use in the treatment of tumor diseases.
    Type: Grant
    Filed: September 27, 2004
    Date of Patent: October 5, 2010
    Assignee: R&D-Biopharmaceuticals GmbH
    Inventors: Wolfgang Richter, Bernd Henkel, Michael W. Cappi
  • Tubulysin conjugates
    Patent number: 7776814
    Abstract: The invention relates to novel tubulysin conjugates (e.g. of tubulysin A) and the use thereof in the treatment of cancer diseases.
    Type: Grant
    Filed: July 9, 2003
    Date of Patent: August 17, 2010
    Assignee: R&D-Biopharmaceuticals GmbH
    Inventors: Alexander Dömling, Lutz Weber